Related references
Note: Only part of the references are listed.Identification of a disruptor of the MDM2-p53 protein-protein interaction facilitated by high-throughput in silico docking
Harshani R. Lawrence et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx
Anna Czarna et al.
CELL CYCLE (2009)
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
Marzena Pazgiera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
BH3 activation blocks Hdmx suppression of apoptosis and cooperates with Nutlin to induce cell death
Mark Wade et al.
CELL CYCLE (2008)
Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation
Mingxuan Xia et al.
CELL CYCLE (2008)
Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain
Grzegorz M. Popowicz et al.
CELL CYCLE (2008)
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
Sanjeev Shangary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
p53 regulates maternal reproduction through LIF
Wenwei Hu et al.
NATURE (2007)
Molecular basis for the inhibition of p53 by Mdmx
Grzegorz M. Popowicz et al.
CELL CYCLE (2007)
Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX
Baoli Hu et al.
CANCER RESEARCH (2007)
Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide
Federico Bernal et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
MDMX regulation of p53 response to ribosomal stress
Daniele M. Gilkes et al.
EMBO JOURNAL (2006)
MDMX overexpression prevents p53 activation by the MDM2 inhibitor nutlin
Baoli Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Hdmx modulates the outcome of P53 activation in human tumor cells
Mark Wade et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Inactivation of the p53 pathway in retinoblastoma
Nikia A. Laurie et al.
NATURE (2006)
Levels of HdmX expression dictate the sensitivity of normal and transformed cells to nutlin-3
JT Patton et al.
CANCER RESEARCH (2006)
Structure-activity studies in a family of β-hairpin protein epitope mimetic inhibitors of the p53-HDM2 protein-protein interaction
R Fasan et al.
CHEMBIOCHEM (2006)
The central region of HDM2 provides a second binding site for p53
GW Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Divorcing ARF and p53: an unsettled case
Charles J. Sherr
NATURE REVIEWS CANCER (2006)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
MDM2 promotes ubiquitination and degradation of MDMX
Y Pan et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence
A Takaoka et al.
NATURE (2003)
Tobacco etch virus protease:: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency
RB Kapust et al.
PROTEIN ENGINEERING (2001)
Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53
J Parant et al.
NATURE GENETICS (2001)
Share Paper
